Ariana Pharma
The AI engine Fit Assessment
BetaAriana Pharma effectively leverages machine learning and advanced analytics to discover patterns, expand therapeutics, and identify biomarkers, enhancing drug development processes.
Blurb
Ariana Pharma is a premium provider of advanced, clinical and biomarker data analytics technology.
HQ Location
Paris (France)
Founded
2003
Employees
11 - 50
Total funding raised
$2.30M
Last Funding Event
Series A, $2.30M, July 9, 2008
Smart insights
- Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
- Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
- 6m headcount growth: 25%
- 1Y headcount growth: 94%
- Headcount-to-last-round ratio: 5.3 employees/$M
Subspaces
- Biomarker Identification
Developer of biomarker data insights and diagnostic testing technology designed to accelerate drug discovery and development. The company's technology provides Knowledge Management and Extraction (KEM), a decision support system for testing and providing insights on multi-parametric and multi-objective data, enabling clients to access intelligent data insights and consultancy to go beyond conventional statistics and enrich clinical processes.